John G. Cox
2013
In 2013, John G. Cox earned a total compensation of $3.7M as EVP, Pharmaceutical Operations and Technology at Biogen, a 10% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $5,730 |
|---|---|
| Non-Equity Incentive Plan | $591,273 |
| Salary | $625,648 |
| Stock Awards | $2,247,885 |
| Other | $201,061 |
| Total | $3,671,597 |
Cox received $2.2M in stock awards, accounting for 61% of the total pay in 2013.
Cox also received $5.7K of change in pension value and nonqualified deferred compensation earnings, $591.3K in non-equity incentive plan, $625.6K in salary and $201.1K in other compensation.
Rankings
In 2013, John G. Cox's compensation ranked 1,969th out of 12,286 executives tracked by ExecPay. In other words, Cox earned more than 84.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,969 out of 12,286 | 84th |
Division Manufacturing | 647 out of 4,612 | 86th |
Major group Chemicals And Allied Products | 180 out of 1,466 | 88th |
Industry group Drugs | 121 out of 1,160 | 90th |
Industry Biological Products, Except Diagnostic Substances | 15 out of 200 | 93rd |
Source: SEC filing on April 15, 2016.
Cox's colleagues
We found five more compensation records of executives who worked with John G. Cox at Biogen in 2013.